0001697751-20-000001.txt : 20200611 0001697751-20-000001.hdr.sgml : 20200611 20200611113640 ACCESSION NUMBER: 0001697751-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200611 DATE AS OF CHANGE: 20200611 EFFECTIVENESS DATE: 20200611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AsclepiX Therapeutics, Inc. CENTRAL INDEX KEY: 0001697751 IRS NUMBER: 832160334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368730 FILM NUMBER: 20956609 BUSINESS ADDRESS: STREET 1: 301 WEST 29TH STREET, SUITE 2004 CITY: BALTIMORE STATE: MD ZIP: 21211 BUSINESS PHONE: 610-212-1217 MAIL ADDRESS: STREET 1: 301 WEST 29TH STREET, SUITE 2004 CITY: BALTIMORE STATE: MD ZIP: 21211 FORMER COMPANY: FORMER CONFORMED NAME: AsclepiX Therapeutics, LLC DATE OF NAME CHANGE: 20170209 D 1 primary_doc.xml X0708 D LIVE 0001697751 AsclepiX Therapeutics, Inc. 301 WEST 29TH STREET, SUITE 2004 BALTIMORE MD MARYLAND 21211 610-212-1217 DELAWARE AsclepiX Therapeutics, LLC Corporation true Jordan J. Green 301 West 29th Street, Suite 2004 Baltimore MD MARYLAND 21211 Director Aleksander S. Popel, PhD 301 West 29th Street, Suite 2004 Baltimore MD MARYLAND 21211 Director Kevin Slawin, MD 301 West 29th Street, Suite 2004 Baltimore MD MARYLAND 21211 Executive Officer Director Joshua Barer 301 West 29th Street, Suite 2004 Baltimore MD MARYLAND 21211 Director Sapna Srivastava 301 West 29th Street, Suite 2004 Baltimore MD MARYLAND 21211 Director Steven Altschuler, MD 301 West 29th Street, Suite 2004 Baltimore MD MARYLAND 21211 Director Biotechnology Decline to Disclose 06b false 2020-05-27 false true false 0 35000000 10000000 25000000 false 34 0 0 0 false AsclepiX Therapeutics, Inc. /s/Kevin Slawin, M.D. Kevin Slawin, M.D. Interim Chief Executive Officer 2020-06-11